Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT) 2A and 5-HT2C receptors PR Moya, KA Berg, MA Gutierrez-Hernandez, P Saez-Briones, ... Journal of Pharmacology and Experimental Therapeutics 321 (3), 1054-1061, 2007 | 127 | 2007 |
Monoamine oxidase inhibitory properties of some methoxylated and alkylthio amphetamine derivatives: structure–activity relationships MC Scorza, C Carrau, R Silveira, G Zapata-Torres, BK Cassels, ... Biochemical pharmacology 54 (12), 1361-1369, 1997 | 109 | 1997 |
Sulfur-substituted α-alkyl phenethylamines as selective and reversible MAO-A inhibitors: Biological activities, CoMFA analysis, and active site modeling A Gallardo-Godoy, A Fierro, TH McLean, M Castillo, BK Cassels, ... Journal of medicinal chemistry 48 (7), 2407-2419, 2005 | 104 | 2005 |
Prenatal to early postnatal nicotine exposure impairs central chemoreception and modifies breathing pattern in mouse neonates: a probable link to sudden infant death syndrome J Eugenín, M Otárola, E Bravo, C Coddou, V Cerpa, M Reyes-Parada, ... Journal of Neuroscience 28 (51), 13907-13917, 2008 | 93 | 2008 |
Effects of the D3 preferring dopamine agonist pramipexole on sleep and waking, locomotor activity and striatal dopamine release in rats P Lagos, C Scorza, JM Monti, H Jantos, M Reyes-Parada, R Silveira, ... European Neuropsychopharmacology 8 (2), 113-120, 1998 | 81 | 1998 |
p‐Methylthioamphetamine and 1‐(m‐chlorophenyl)piperazine, two non‐neurotoxic 5‐HT releasers in vivo, differ from neurotoxic amphetamine derivatives in their mode of … M Gobbi, M Moia, L Pirona, I Ceglia, M Reyes‐Parada, C Scorza, ... Journal of neurochemistry 82 (6), 1435-1443, 2002 | 69 | 2002 |
Synthesis, biological evaluation, and molecular simulation of chalcones and aurones as selective MAO‐B inhibitors N Morales‐Camilo, CO Salas, C Sanhueza, C Espinosa‐Bustos, ... Chemical biology & drug design 85 (6), 685-695, 2015 | 66 | 2015 |
2-Arylthiomorpholine derivatives as potent and selective monoamine oxidase B inhibitors S Lühr, M Vilches-Herrera, A Fierro, RR Ramsay, DE Edmondson, ... Bioorganic & medicinal chemistry 18 (4), 1388-1395, 2010 | 48 | 2010 |
Heteroarylisopropylamines as MAO inhibitors G Vallejos, A Fierro, MC Rezende, S Sepúlveda-Boza, M Reyes-Parada Bioorganic & medicinal chemistry 13 (14), 4450-4457, 2005 | 45 | 2005 |
Naphthylisopropylamine and N-benzylamphetamine derivatives as monoamine oxidase inhibitors M Vilches-Herrera, J Miranda-Sepúlveda, M Rebolledo-Fuentes, A Fierro, ... Bioorganic & medicinal chemistry 17 (6), 2452-2460, 2009 | 41 | 2009 |
Effects of 5-HT-releasing agents on the extracellullar hippocampal 5-HT of rats. Implications for the development of novel antidepressants with a short onset of action C Scorza, R Silveira, DE Nichols, M Reyes-Parada Neuropharmacology 38 (7), 1055-1061, 1999 | 41 | 1999 |
MDMA (“ecstasy”) impairs learning in the Morris Water Maze and reduces hippocampal LTP in young rats A Arias-Cavieres, C Rozas, M Reyes-Parada, N Barrera, F Pancetti, ... Neuroscience letters 469 (3), 375-379, 2010 | 38 | 2010 |
Depletion of brain serotonin by 5, 7-DHT: effects on the 8-OH-DPAT-induced changes of sleep and waking in the rat JM Monti, H Jantos, R Silveira, M Reyes-Parada, C Scorza, G Prunell Psychopharmacology 115, 273-277, 1994 | 38 | 1994 |
A Comparative In Vitro Study of the Neuroprotective Effect Induced by Cannabidiol, Cannabigerol, and Their Respective Acid Forms: Relevance of the 5-HT 1A Receptors C Echeverry, G Prunell, C Narbondo, VS de Medina, X Nadal, ... Neurotoxicity Research 39, 335-348, 2021 | 36 | 2021 |
Changes in antioxidant capacity of Tannat red wines during early maturation C Echeverry, M Ferreira, M Reyes-Parada, JA Abin-Carriquiry, F Blasina, ... Journal of food engineering 69 (2), 147-154, 2005 | 36 | 2005 |
Monoamine oxidase inhibition in the light of new structural data M Reyes-Parada, A Fierro, P Iturriaga-Vásquez, BK Cassels Current Enzyme Inhibition 1 (1), 85-95, 2005 | 31 | 2005 |
Multiple binding sites in the nicotinic acetylcholine receptors: An opportunity for polypharmacolgy P Iturriaga-Vásquez, J Alzate-Morales, I Bermudez, R Varas, ... Pharmacological Research 101, 9-17, 2015 | 30 | 2015 |
Sleep and waking in 5, 7-DHT-lesioned or (−)-pindolol-pretreated rats after administration of buspirone, ipsapirone, or gepirone JM Monti, H Jantos, R Silveira, M Reyes-Parada, C Scorza Pharmacology Biochemistry and Behavior 52 (2), 305-312, 1995 | 30 | 1995 |
Characterization of a Novel Drosophila SERT Mutant: Insights on the Contribution of the Serotonin Neural System to Behaviors S Hidalgo, D Molina-Mateo, P Escobedo, RV Zárate, E Fritz, A Fierro, ... ACS chemical neuroscience 8 (10), 2168-2179, 2017 | 29 | 2017 |
Human and rat monoamine oxidase-A are differentially inhibited by (S)-4-alkylthioamphetamine derivatives: Insights from molecular modeling studies A Fierro, M Osorio-Olivares, BK Cassels, DE Edmondson, ... Bioorganic & medicinal chemistry 15 (15), 5198-5206, 2007 | 28 | 2007 |